ALX Oncology Ownership | Who Owns ALX Oncology?

ALX Oncology Ownership Summary

ALX Oncology is owned by 77.92% institutional investors, 2.08% insiders, and 20.00% retail investors. Venbio partners is the largest institutional shareholder, holding 18.41% of ALXO shares. HBM Healthcare Investments AG Ord is the top mutual fund, with 6.50% of its assets in ALX Oncology shares.

ALXO Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	ALX Oncology	77.92%	2.08%	20.00%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Venbio partners	9.70M	18.41%	$16.20M
Redmile group	3.69M	7.00%	$6.16M
Tang capital management	3.30M	6.26%	$5.51M
Blackrock	2.69M	5.36%	$16.21M
Blackrock funding, inc. /de	2.38M	4.52%	$3.98M
Millennium management	2.13M	4.04%	$3.56M
Vanguard group	1.89M	3.58%	$3.15M
Fmr	1.85M	3.51%	$3.09M
Bioimpact capital	1.39M	2.64%	$2.32M
Almitas capital	1.22M	2.32%	$2.04M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Venbio partners	9.70M	9.49%	$16.20M
Almitas capital	1.22M	0.45%	$2.04M
Redmile group	3.69M	0.43%	$6.16M
Tang capital management	3.30M	0.36%	$5.51M
Bioimpact capital	1.39M	0.33%	$2.32M
Privium fund management b.v.	509.06K	0.19%	$850.13K
Affinity asset advisors	100.00K	0.07%	$603.00K
Nan fung group	41.95K	0.06%	$70.06K
Xtx topco	263.86K	0.04%	$440.64K
Hc advisors	15.47K	0.02%	$25.84K

Top Buyers

Holder	Shares	% Assets	Change
Almitas capital	1.22M	0.45%	1.22M
Bank of montreal /can/	826.58K	0.00%	826.58K
Acadian asset management	1.11M	0.01%	683.02K
Blackrock	2.69M	0.00%	466.06K
Ubs group	408.06K	0.00%	378.82K

Top Sellers

Holder	Shares	% Assets	Change
Vivo capital	-	-	-4.03M
Fmr	1.85M	0.00%	-4.01M
Vestal point capital, lp	-	-	-3.60M
Cormorant asset management, lp	-	-	-3.14M
Orbimed advisors	-	-	-1.89M

New Positions

Holder	Shares	% Assets	Change	Value
Almitas capital	1.22M	0.45%	1.22M	$2.04M
Bank of montreal /can/	826.58K	0.00%	826.58K	$1.38M
Jacobs levy equity management	232.02K	0.01%	232.02K	$1.40M
Bank of nova scotia	105.31K	0.00%	105.31K	$175.86K
Affinity asset advisors	100.00K	0.07%	100.00K	$603.00K

Sold Out

Holder	Change
Allspring global investments	-2.00
Farther finance advisors	-4.00
Creekmur asset management	-4.00
Gamma investing	-12.00
Capital performance advisors llp	-20.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	93	-2.11%	41,059,279	-9.68%	77	1.05%	52	-10.34%	21	-4.55%
Sep 30, 2024	95	-18.80%	45,459,170	-6.37%	86	0.92%	58	-15.94%	22	-15.38%
Jun 30, 2024	117	4.46%	48,553,785	6.04%	96	1.16%	69	32.69%	26	-16.13%
Mar 31, 2024	112	14.29%	45,786,300	0.25%	91	0.81%	52	-21.21%	31	93.75%
Dec 31, 2023	98	20.99%	45,673,866	37.23%	106	1.62%	66	88.57%	16	-30.43%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
HBM Healthcare Investments AG Ord	3.43M	6.50%	1.93M
Vanguard Total Stock Mkt Idx Inv	984.59K	1.84%	-
Vanguard US Total Market Shares ETF	984.59K	1.84%	-
iShares Russell 2000 ETF	884.02K	1.66%	-7.64K
Fidelity Select Biotechnology	835.50K	1.58%	-
Fidelity Stock Selector Small Cap	837.11K	1.57%	10.71K
Fidelity Series Small Cap Opps	769.53K	1.44%	-
Fidelity Small Cap Value Fund	678.40K	1.29%	-
Biotech Growth Ord	512.26K	0.97%	105.00K
Fidelity Small Cap Growth	432.37K	0.82%	-1.26M

Recent Insider Transactions

Date	Name	Role	Activity	Value
Feb 19, 2025	Pinto Shelly	SVP, FINANCE AND CAO	Sell	$632.61
Feb 19, 2025	Pons Jaume	PRESIDENT & CSO	Sell	$1.53K
Feb 19, 2025	Lettmann Jason	CHIEF EXECUTIVE OFFICER	Sell	$2.48K
Jan 06, 2025	Pinto Shelly	Interim CFO	Sell	$4.00K
Dec 30, 2024	Pinto Shelly	Interim CFO	Sell	$2.25K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	4
2024 Q4	1	2
2024 Q3	-	8
2024 Q2	1	6
2024 Q1	1	1

ALXO Ownership FAQ

Who Owns ALX Oncology?

ALX Oncology shareholders are primarily institutional investors at 77.92%, followed by 2.08% insiders and 20.00% retail investors. The average institutional ownership in ALX Oncology's industry, Biotech Stocks , is 68.48%, which ALX Oncology exceeds.

Who owns the most shares of ALX Oncology?

ALX Oncology’s largest shareholders are Venbio partners (9.7M shares, 18.41%), Redmile group (3.69M shares, 7.00%), and Tang capital management (3.3M shares, 6.26%). Together, they hold 31.67% of ALX Oncology’s total shares outstanding.

Does Blackrock own ALX Oncology?

Yes, BlackRock owns 5.36% of ALX Oncology, totaling 2.69M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 16.21M$. In the last quarter, BlackRock increased its holdings by 466.06K shares, a 20.98% change.

Who is ALX Oncology’s biggest shareholder by percentage of total assets invested?

Venbio partners is ALX Oncology’s biggest shareholder by percentage of total assets invested, with 9.49% of its assets in 9.7M ALX Oncology shares, valued at 16.2M$.

Who is the top mutual fund holder of ALX Oncology shares?

HBM Healthcare Investments AG Ord is the top mutual fund holder of ALX Oncology shares, with 6.50% of its total shares outstanding invested in 3.43M ALX Oncology shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools